Ironwood Pharmaceuticals | GJELD



Debt Endring Dato
Acadia Pharmaceuticals USD 0 0 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
Almirall EUR 408.66M 56.36M 2024-06
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amarin USD 0 0 2024-09
Ardelyx USD 150.85M 50.15M 2024-12
Astellas Pharma JPY 915.36B 12.13B 2024-12
AstraZeneca USD 30.3B 1.27B 2024-12
Charles River Laboratories USD 2.24B 86.72M 2024-12
Exact Sciences USD 2.59B 8K 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Incyte USD 37.96M 5.81M 2024-12
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
MacroGenics USD 0 0 2024-12
Moderna USD 62M 593M 2024-12
Myriad Genetics USD 39.6M 600K 2024-12
Pacira USD 585.32M 2.04M 2024-12
PTC Therapeutics USD 2.39B 389K 2024-12
Sarepta Therapeutics USD 1.14B 90.44M 2024-12
Takeda JPY 4.84T 211.04B 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12



Ironwood Pharmaceuticals GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.